Raffa Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Raffa Wealth Management's JAZZ Position: Q3 2026 in Review
Raffa Wealth Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 2 shares worth $463. The position accounts for ﹤0.01% of the portfolio, ranked #1205.
Raffa Wealth Management first reported a position in JAZZ in Q1 2015 and has held it in 10 quarters since. The position peaked at $1.58K in Q2 2015. 669 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Raffa Wealth Management held 2 shares of Jazz Pharmaceuticals worth $463 as of Q3 2026.
- Raffa Wealth Management left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1205 holding.
- Raffa Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 10 quarters since.
- Raffa Wealth Management's Jazz Pharmaceuticals position peaked at $1.58K in Q2 2015.
- 669 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.